Elsevier

Neuropharmacology

Volume 26, Issue 6, June 1987, Pages 531-539
Neuropharmacology

Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptyline

https://doi.org/10.1016/0028-3908(87)90144-4Get rights and content

Abstract

The central mechanism responsible for the potentiation by antidepressant drugs of analgesia induced by morphine, was explored by measuring the levels of various neuropeptides (met-enkephalin, leu-enkephalin, dynorphin, substance P and cholecystokinin-like materials) and the density of delta and mu opioid binding sites in the spinal cord of rats treated for 14 days with amoxapine (10 mg/kg i.p., daily) or amitriptyline (10 mg/kg i.p., daily). Similar measurements were made in the hypothalamus and cerebral cortex for comparison. Chronic treatment with amoxapine or amitriptyline did not affect the levels of dynorphin, substance P and cholecystokinin, but markedly enhanced the levels of leu-enkephalin in the three structures examined. The levels of met-enkephalin were also increased after treatment with amitriptyline but only in the spinal cord and hypothalamus. No changes in opioid receptors were found in the cerebral cortex, but the densities of delta and mu opioid binding sites were increased in the spinal cord, and decreased in the hypothalamus of rats treated with amoxapine or amitriptyline. These changes induced by antidepressants in opioidergic markers at the spinal level might account for the potentiation of the action of morphine in amoxapine- or amitriptyline-treated rats. In addition, the observed alterations in the same markers in the hypothalamus could be associated with changes induced by antidepressants in neuroendocrine regulation.

References (50)

  • F.J. Goldstein et al.

    Elevation in analgesic effect and plasma levels of morphine by desipramine in rats

    Pain

    (1982)
  • J.-S. Han et al.

    Is cholecystokinin octapeptide (CCK-8) a candidate for endogenous anti-opioid substrates?

    Neuropeptides

    (1985)
  • J.S. Hong et al.

    Repeated electro-convulsive shocks alter the biosynthesis of enkephalin and concentration of dynorphin in the rat brain

    Neuropeptides

    (1985)
  • Z.S. Herman et al.

    Leu-enkephalin content in rat brain during prolonged treatment with imipramine or amitriptyline

    Neuropeptides

    (1986)
  • D. Jordan et al.

    In vitro effects of endogenous opiate peptides on thyrotropin function: inhibition of thyrotropin releasing hormone release and absence of effect on thyrotropin release

    Neurosci. Lett.

    (1986)
  • A.A. Larson et al.

    The potentiation of spinal analgesia by leucine enkephalin

    Eur. J. Pharmac.

    (1980)
  • C. Lighton et al.

    Increase in levels and ex vivo release of thyrotropinreleasing hormone (TRH) in specific regions of the CNS of the rat by chronic treatment with antidepressants

    Neuropharmacology

    (1985)
  • S.J. Liu et al.

    Increased sensitivity of the central nervous system to morphine analgesia by amitriptyline in naive and morphine-tolerant rats

    Biochem. Pharmac.

    (1981)
  • O.H. Lowry et al.

    Protein measurement with the Folin phenol reagent

    J. biol. Chem.

    (1951)
  • D. Luttinger et al.

    Peptides and nociception

    Int. Rev. Neurobiol.

    (1984)
  • R.T. Malseed et al.

    Enhancement of morphine analgesia by tricyclic antidepressants

    Neuropharmacology

    (1979)
  • A. Mauborgne et al.

    Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains

    Brain Res.

    (1983)
  • Y. Nakata et al.

    Repeated electroconvulsive shock downregulates the opioid receptors in rat brain

    Brain Res.

    (1985)
  • I. Pilowsky et al.

    A controlled study of amitriptyline in the treatment of chronic pain

    Pain

    (1982)
  • M. Raiteri et al.

    Differential binding of antidepressants to noradrenaline and serotonin transport sites in central nerve endings

    Eur. J. Pharmac.

    (1979)
  • Cited by (81)

    • Antidepressants as Analgesics

      2013, Practical Management of Pain: Fifth Edition
    • Antidepressants as Analgesics

      2013, Practical Management of Pain: Fifth Edition
    • Effect of amitriptyline on glycinergic transmission in rat medullary dorsal horn neurons

      2012, Brain Research
      Citation Excerpt :

      For example, amitriptyline blocks various subtypes of VDNCs, including TTX-sensitive and TTX-resistant Na+ channels, in a state-dependent manner in sensory neurons (Bräu et al., 2001; Dick et al., 2007; Hur et al., 2008). Other mechanisms might include the inhibition of norepinephrine and/or serotonin reuptake in the spinal dorsal horn (Taiwo et al., 1985), the inhibition of various ligand-gated ion channels, such as nicotinic acetylcholine receptors (Freysoldt et al., 2009), NMDA receptors (Reynolds and Miller, 1988), P2X receptors (Nagata et al., 2009; but see also Sim and North, 2010), and the direct and indirect effects on μ-opioid receptors (Hamon et al., 1987; Isenberg and Cicero, 1984). In the present study, we found that amitriptyline at ≥ 10 μM concentrations significantly enhanced spontaneous glycine release onto medullary dorsal horn neurons.

    • Ketanserin potentiates morphine-induced antinociception mediated by kappa-receptor activation

      2011, Pharmacological Research
      Citation Excerpt :

      Although this study cannot rule out the influence of other neurotransmitters mediating MAE, such as noradrenaline or dopamine, which can also be stimulated by morphine [29,31] and regulated by 5-HT [32,33], there is good evidence that kappa receptors play a crucial role in nociception. This action could be mu-opioid receptor independent [8–34] and related to 5-HT modulation [35,36]. Our results point at new potential therapeutic applications of kappa-opioid receptor ligands and encourage new efforts in the development of ligands for these receptors as potential analgesics [37,38].

    View all citing articles on Scopus
    View full text